Reddit Inc vs Travere Therapeutics Inc. Common Stock — how do they compare? Reddit Inc trades at $146 (market cap $29.88B), while Travere Therapeutics Inc. Common Stock trades at $52.74 (market cap $4.88B). The key difference: Reddit Inc is far larger — about 6.1× Travere Therapeutics Inc. Common Stock's market cap, and Travere Therapeutics Inc. Common Stock is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Reddit Inc for 27 Days and Travere Therapeutics Inc. Common Stock for 0 Days on average.
| RDDT | TVTX | |
|---|---|---|
Market Cap | $29.88B | $4.88B |
Volume | 4,920,505 | 1,668,577 |
Sector | Media | Health |
52-Week High | $258.93 | $67.52 |
52-Week Low | $121.84 | $26.79 |
Typical Hold Time | 27 Days | 0 Days |
Enterprise Value | $27.11B | $5.01B |
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $155.09, down 3.0% on the day, with strong fundamental performance including 31.35% net income margin and consistent earnings beats. The stock shows bullish technical signals with support at $154 and resistance at $164, while analyst consensus remains strongly positive with a $202.52 price target. Recent developments include strategic partnerships for advertising insights and ongoing expansion of its data licensing business.
The outlook remains favorable given robust profitability, growing revenue trajectory, and Wall Street's bullish stance, though risks include competitive pressures in social media advertising and potential volatility from recent CEO share sales. The stock presents a compelling opportunity for growth investors seeking exposure to a profitable social media platform with strong AI data licensing potential.
Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.
The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →Travere Therapeutics Inc. is a biopharmaceutical company focused on rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral medication for adults with IgA nephropathy, and it also markets Thiola for cystinuria.
Read more on TVTX →